Tag:

GRNOPC1

Latest Headlines

Latest Headlines

FDA approves first stem cell trial

The FDA has approved the first trial of a therapy derived from embryonic stem cells. The trial--run by Menlo Park, CA-based Geron--will test GRNOPC1 in patients with acute spinal cord injury. The